JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

PerkinElmer Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-8.6M

47M

Sales

-21M

699M

P/E

Sector Avg

50.083

37.003

EPS

0.4

Dividend yield

0.28

Profit margin

6.675

Employees

11,000

EBITDA

-14M

181M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+15.19% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.28%

2.25%

Next Dividend date

7 lis 2025

Next Ex Dividend date

16 sty 2026

Market Stats

By TradingEconomics

Market Cap

584M

11B

Previous open

0

Previous close

0

News Sentiment

By Acuity

31%

69%

98 / 373 Ranking in Healthcare

PerkinElmer Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 paź 2025, 23:28 UTC

Hot Stocks

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29 paź 2025, 23:07 UTC

Earnings

Prudential PLC 3Q New Business Profit Up 13%

30 paź 2025, 00:00 UTC

Earnings

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30 paź 2025, 00:00 UTC

Earnings

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30 paź 2025, 00:00 UTC

Earnings

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29 paź 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29 paź 2025, 23:40 UTC

Earnings

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29 paź 2025, 23:38 UTC

Market Talk

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29 paź 2025, 23:25 UTC

Earnings

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29 paź 2025, 22:51 UTC

Earnings

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29 paź 2025, 22:45 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29 paź 2025, 22:41 UTC

Earnings

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29 paź 2025, 22:41 UTC

Earnings

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29 paź 2025, 22:09 UTC

Earnings

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29 paź 2025, 22:08 UTC

Market Talk
Earnings

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29 paź 2025, 21:58 UTC

Earnings

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29 paź 2025, 21:58 UTC

Earnings

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29 paź 2025, 21:57 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29 paź 2025, 21:54 UTC

Earnings

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29 paź 2025, 21:46 UTC

Earnings

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29 paź 2025, 21:43 UTC

Earnings

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29 paź 2025, 21:43 UTC

Earnings

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29 paź 2025, 21:42 UTC

Earnings

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29 paź 2025, 21:42 UTC

Earnings

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29 paź 2025, 21:41 UTC

Earnings

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29 paź 2025, 21:41 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29 paź 2025, 21:41 UTC

Earnings

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29 paź 2025, 21:41 UTC

Earnings

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29 paź 2025, 21:40 UTC

Earnings

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29 paź 2025, 21:39 UTC

Earnings

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Peer Comparison

Price change

PerkinElmer Inc Forecast

Price Target

By TipRanks

15.19% upside

12 Months Forecast

Average 111.1 USD  15.19%

High 125 USD

Low 100 USD

Based on 11 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

8

Buy

3

Hold

0

Sell

Sentiment

By Acuity

98 / 373 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat